A strategy of idarucizumab for pericardial tamponade during perioperative period of atrial fibrillation ablation

Objective To investigate theoptimal idarucizumab (dabigatran antagonist) usage strategy for patients with acute pericardial tamponade receiving uninterrupted dabigatran during catheter ablation for atrial fibrillation (AF). Methods Ten patients presenting acute pericardial tamponade while receiving...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pacing and clinical electrophysiology 2021-11, Vol.44 (11), p.1824-1831
Hauptverfasser:	Zhao, Xin, Chen, Li‐zhu, Su, Xin, Long, De‐yong, Sang, Cai‐hua, Yu, Rong‐Hui, Tang, Ri‐bo, Bai, Rong, Liu, Nian, Jiang, Chen‐xi, Li, Song‐nan, Guo, Xue‐yuan, Wang, Wei, Du, Xin, Dong, Jian‐zeng, Ma, Chang‐sheng
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation Aged Antibodies, Monoclonal, Humanized - administration & dosage Antithrombins - administration & dosage atrial fibrillation Atrial Fibrillation - surgery Cardiac arrhythmia Cardiac Tamponade - drug therapy Cardiac Tamponade - etiology Catheter Ablation Catheters Clopidogrel Dabigatran - administration & dosage Embolism Female Fibrillation Hemostasis Humans idacezumab Male Middle Aged Monoclonal antibodies Patients pericardial tamponade Perioperative Period Protamine Retrospective Studies Surgical drains Tamponade uninterrupted dabigatran
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!